← Back to headlines
China Accepts Novo Nordisk Application for Oral Version of Wegovy
China’s National Medical Products Administration has officially accepted Novo Nordisk’s regulatory filing for an oral formulation of its popular weight-management drug Wegovy. The approval process could significantly expand patient access to the medication in the world’s second-largest pharmaceutical market.
27 Aug, 03:47 — 27 Aug, 04:49
The Story
Analyzing sources…
Source Diversity
Source Diversity
Low (24/100)2 sources— more sources would strengthen this score15/33
Spectrum spread— 1/5 buckets covered0/33
Far L
Left
Center2
Center (2)
investing-comReuters
Right
Far R
Geographic diversity— 2 regions9/34
US1Intl1
ℹOnly 2 sources cover this story
Sources
Showing 2 of 2 sources
ReutersVery High5d ago
China's drug regulator accepts Novo Nordisk's application for oral Wegovy - Reuters
China's drug regulator accepts Novo Nordisk's application for oral Wegovy Reuters
Read full article →investing-com5d ago
China’s drug regulator accepts Novo Nordisk’s application for oral Wegovy
By Reuters
Read full article →Coverage Timeline
First report: Reuters · 27 Aug, 03:47|Full coverage: 2 · 1h|Window: 1h
Left-leaningCenterRight-leaning
